Skip to main content

Table 2 Multivariate analysis of factors associated with alcohol abuse among HIV positive patients (n = 343)

From: Alcohol use disorders among people living with HIV/AIDS in Southern Brazil: prevalence, risk factors and biological markers outcomes

Variable n (%) Crude PR (95CI) p Adjusted PR (95CI) p
Genderc,f
 Female 27 (16.0) 1 0.001 1 0.001
 Male 71 (40.8) 2.55 (1.73–3.77) 2.88 (1.96–4.24)
Agec,f
 18–34 27 (27.3) 1 0.5b 1 0.08a
 35–54 59 (30.7) 1.13 (0.76–1.66) 0.81 (0.56–1.16)
 55 or older 12 (23.1) 0.85 (0.47–1.53) 0.61 (0.34–1.10)
Skin colorc,f
 White 60 (25.2) 1 0.01a 1 0.04a
 Mixed 17 (30.9) 1.23 (0.80–1.93) 1.10 (0.74–1.65)
 Black 21 (42.0) 1.67 (1.12–2.47) 1.44 (0.98–2.13)
Educationc,f
 Each year   0.93 (0.89–0.98) 0.005 0.95 (0.90–0.99) 0.03
Income (quartiles)c,f
 1st 22 (23.7) 1 0.006b 1 0.003b
 2nd 33 (40.2) 1.70 (1.08–2.67) 1.67 (1.08–2.60)
 3rd 29 (34.1) 1.44 (0.90–2.31) 1.18 (0.75–1.88)
 4th 14 (16.9) 0.71 (0.39–1.30) 0.67 (0.37–1.21)
Married/Cohabitingc
 No 53 (30.8) 1 0.3 1 0.7
 Yes 45 (26.3) 0.85 (0.61–1.20) 0.94 (0.69–1.29)
STDd
 No 80 (26.6) 1 0.02 1 0.5
 Yes 18 (42.9) 1.61 (1.08–2.40) 1.15 (0.79–1.68)
Number sexual partnersd
 Up to 2 76 (26.4) 1 0.03 1 0.2
 3 or more 22 (40.0) 1.52 (1.04–2.21) 1.25 (0.90–1.74)
Use of intravenous drugsd,f
 No 70 (23.6) 1 0.001 1 0.03
 Yes 28 (60.9) 2.58 (1.89–3.52) 1.45 (1.04–2.02)
Use of inhaled illicit drugsd,f
 No 43 (18.5) 1 0.001 1 0.001
 Yes 55 (49.5) 2.67 (1.92–3.71) 1.85 (1.28–2.68)
Previous hepatitisd
 No 71 (25.8) 1 0.02 1 0.5
 Yes 27 (39.7) 1.54 (1.08–2.19) 1.14 (0.80–1.60)
Length of HIV infectione
 Each year   0.997 (0.965–1.031) 0.9 0.989 (0.957–1.021) 0.5
Use of HAARTe
 No 7 (18.9) 1 0.2 1 0.2
 Yes 91 (29.7) 1.57 (0.79–3.13) 1.69 (0.81–3.54)
  1. aLinear trend test; bHeterogeneity test; c1st level; d2nd level; e3rd level; ffinal model